Full Press Release Details
CAMBRIDGE, Mass., Aug. 10, 2016 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on the development of potentially curative therapeutics using CRISPR/Cas9 technology, announced that CEO and Founder Nessan Bermingham, Ph.D., will present at the 2016 Wedbush PacGrow Healthcare Conference.
Details of the presentation are as follows:
2016 Wedbush PacGrow Healthcare Conference
Date: Wednesday, August 17th
Location: Le Parker Meridien, New York
Presentation Time: 10:55 AM EST
Individuals may access a live webcast of the presentation on the Intellia website at www.intelliatx.com under "Upcoming Events" in the "Events & Presentations" section. A replay of the webcast will be available on this site for 90 days following the live event.
About Intellia Therapeutics